Left ventricular mass and hemodynamic overload in normotensive hemodialysis patients  by Lin, Yao-Ping et al.
Kidney International, Vol. 62 (2002), pp. 1828–1838
Left ventricular mass and hemodynamic overload in
normotensive hemodialysis patients
YAO-PING LIN, CHEN-HUAN CHEN, WEN-CHUNG YU, TSEI-LIEH HSU, PHILIP YU-AN DING, and
WU-CHANG YANG
Department of Medicine, Taipei Veterans General Hospital and Institute of Clinical Medicine, National Yang-Ming University,
Taipei, Taiwan, Republic of China
Left ventricular mass and hemodynamic overload in normoten- Despite considerable advances in the medical care and
sive hemodialysis patients. dialysis facility, cardiovascular disease remains the major
Background. It remains uncertain whether the hemody- cause of death among end-stage renal disease (ERSD)namic parameters are important determinants of left ventricu-
patients [1]. Increased left ventricular mass (LVM), thatlar mass (LVM) in normotensive chronic hemodialysis (NTHD)
is, LV hypertrophy (LVH), is the most frequent cardiacpatients, as has been found in their hypertensive counterparts.
Methods. Forty NTHD patients (mean age, 53.7  14.4 abnormality in patients starting ESRD therapy [2]. LVH
years; male/female, 18/22) without the requirement of antihy- is a strong and independent risk factor for cardiovascular
pertensive drugs for at least six months were studied. Controls morbidity and mortality in both normal population [3]
were 41 hypertensive hemodialysis patients (HTHD) and 46
and the ESRD patients [4]. In ESRD patients, LVH isnormotensive subjects with normal renal function (NTNR).
principally due to an increased demand in LV minute workThe influence of anthropometrics, cardiovascular structure and
function, and volume status on LVM (by two-dimensional resulting from volume/flow and pressure overload [5].
echocardiography) was analyzed by steps of multiple linear Hypertension is present in approximately 80 to 90%
regression. of the ESRD patients and is an important factor for
Results. As compared with the NTNR and NTHD group, the the development of LVH in ESRD patients [6]. TheHTHD group had obvious pressure and volume/flow overload,
presence of hypertension in ESRD patients implies aand greater LV wall thickness, chamber size and mass. In
status of pressure and/or volume overload. Consequently,contrast, NTHD subjects had similar blood pressure, large ar-
tery function, LV chamber size and stroke volume as the NTNR normalization of hypertension by either the use of anti-
subjects. However, the NTHD patients still had greater wall hypertensive agents [7] or adequate ultrafiltration [8]
thickness and LVM, along with greater cardiac output, lower indicates a substantial reduction of the hemodynamic
total peripheral resistance and lower end-systolic meridional
overload [9]. Although pharmacological reduction ofstress to volume ratio (ESSV) than the NTNR group. LVM
high blood pressure has been associated with the reduc-in the NTHD group was significantly positively related to aver-
aged systolic blood pressure (SBPavg), body surface area, ex- tion of the hemodynamic overload and the regression of
tracellular fluid (ECF), carotid intima-media thickness (IMT), LVH in ESRD patients [9], it remains to be demon-
aortic pulse wave velocity (PWV), and negatively related to strated whether normalization of hypertension by ade-
ESSV and Kt/V. The independent significant noncardiac struc- quate dialysis alone is similarly effective in reducing he-tural determinants of LVM in NTHD subjects were ESSV,
modynamic loads and the extent of LVH [10].SBPavg, PWV and SV (model r 2  0.617, P  0.001).
In the present study we comprehensively evaluatedConclusions. The NTHD patients, without significant pres-
sure and volume overload, still had increased LVM that was the hemodynamic determinants of LVM in chronic he-
partially explained by the persistent flow overload and subclini- modialysis (HD) patients whose blood pressures were
cal LV dysfunction. normalized with good fluid control and without the re-
quirement of antihypertensive medication. This is in con-
trast to the majority of previous studies about the deter-
minants of LVM or LVH, which were conducted in ESRD
patients with various degrees of hypertension [11].
Key words: cardiac load, vascular load, blood pressure, dry weight, hemo-
dialysis, end-stage renal disease, two-dimensional echocardiogram.
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(a) had been on HD for at least 6 months; (b) had Anthropometric and volume status measurements
had history of hypertension before or after starting HD Body mass index (BMI) and body surface area (BSA)
therapy; (c) had no previous history of cardiovascular were calculated from weight and height. Waist-to-hip ratio
disease, and (d) had LV ejection fraction (EF) of 55% (WHR) was calculated from waist and hip circumferences
or higher as estimated by M-mode echocardiography. [13]. Fat-free mass (FFM), and extracellular fluid (ECF)
Among the 81 HD patients, 40 attained clinical dry and intracellular fluid (ICF) volumes were measured by
weight and normotension (NTHD) without receiving the multifrequency bioimpedance (Model 4200; Xitron
antihypertensive agents for at least six months, and 41 Technologies, San Diego, CA, USA) method [14].
remained hypertensive (HTHD) under antihypertensive
agent treatment. Dry weight was defined as the lowest Vascular structure and function
body weight in the absence of overt fluid overload that Supine brachial artery systolic (SBP) and diastolic
a patient could tolerate without intradialytic symptoms blood pressures (DBP) were measured with an oscillo-
and hypotension [12]. The etiologies responsible for the metric device. Pulse pressure (PP) was the difference
ESRD included chronic glomerulonephritis (17 NTHD between SBP and DBP. Mean blood pressure (MBP)
and 19 HTHD subjects), nephrosclerosis (6 NTHD and
was PP/3  DBP. End-systolic pressure was defined as
4 HTHD subjects), interstitial nephropathy (5 NTHD
(2SBPDBP)/3 [13]. Common carotid SBP (SBPc) and
and 4 HTHD subjects), diabetic nephropathy (4 NTHD
PP (PPc), which closely reflect the pressure values inand 4 HTHD subjects), polycystic kidney (2 NTHD sub-
the ascending aorta [15], were calculated from the com-jects), systemic lupus erythematosus (4 HTHD subjects),
mon carotid waveform calibrated by the brachial MBPgout (1 NTHD and 1 HTHD subject) and unknown (5
and DBP [16]. Echocardiography was carried out by theNTHD and 5 HTHD subjects). In HTHD, 51.2% of
same experienced cardiologist (C.H.C.). Each echocar-patients received combined antihypertensive medica-
diographic parameter was the mean value from four con-tions of calcium channel blockers plus angiotensin con-
secutive measurements. Aortic root diameter was deter-verting enzyme inhibitors or angiotensin II receptor
mined by M-mode echocardiography (HP sonos 2500 orblockers. The remaining received monotherapy of cal-
5500, Agilent Technology, Andover, MA, USA). Thecium channel blockers or angiotensin-converting enzyme
carotid systolic and diastolic diameters and the intima-inhibitors. All antihypertensives were temporarily dis-
media thickness (IMT) of the posterior wall (distancecontinued on the day of cardiovascular examination. An-
from the leading edge of the lumen-intima interface toother 46 age-matched normotensive subjects with normal
the leading edge of the media-adventitia interface [17])renal function (NTNR) and without history of cardiovas-
were measured on-line from the digitized frozen longitu-cular disease also were enrolled.
dinal images with a 7-MHz vascular probe incorporatedThe hemodynamic examinations were performed on
in the ultrasonographic unit. Carotid incremental elastica mid-week non-dialysis day for the ESRD patients. The
modulus was calculated according to the equation: elasticstudy was approved by the Institutional Review Board of
modulus  (4a2bDP)/[(b2-a2)DD] [18], where a is theTaipei Veterans General Hospital and written informed
internal radius and b is the external radius of the wallconsent was obtained from each patient and normal con-
obtained from the echocardiogram, and DP and DD aretrol at enrollment.
the pressure and diameter changes over the cardiac cycle.
Hemodialysis procedures Of note, DP was calculated by use of PPc.
The wall property of the aorta was indexed by theHemodialysis patients received a four-hour dialysis
truncal pulse wave velocity (PWV). PWV was measuredsession thrice-weekly using 1.6 m2 surface area dialyz-
by recording pulse waves at the right common carotiders with bicarbonate-based dialysate (Na 140 mEq/L,
artery and the right femoral artery sequentially usingHCO3 39 mEq/L, K 2.0 mEq/L, Ca2 3.0 mEq/L and
tonometry and a simultaneous ECG [19]. Carotid aug-Mg2 1.0 mEq/L). The ideal dry weight was assessed via
mentation index (AGI) was analyzed from the right com-meticulous bedside evaluation, which comprises of physi-
mon carotid arterial pressure wave contour [20]. Totalcal examinations and cardiac-thoracic ratio estimated by
arterial compliance (AC) was estimated according to thechest x-ray and echocardiography. If symptoms and signs
diastolic area method [21] that requires a central aorticof fluid overload were noted, the exceeded volume was
pressure wave and a known stroke volume (SV). In thisultrafiltrated during the dialysis session or via additional
study, the central aortic pressure wave was mathemati-sessions. All patients were treated with subcutaneous
cally reconstructed from a tonometer-derived radialrecombinant human erythropoietin (rHuEPO) (Exprex,
pressure wave [22]. Total peripheral vascular resistanceJanssen-Cilag, Schaffhausen, Switzerland) at a mean
(TPR) was calculated as the ratio of MBP to cardiacdosage of 20,000 U per month with an aim to keep their
levels of hematocrit up to 30%. output (CO).
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LV parameters formed with CELL-DYNE 1400 (Abbot Laboratories,
Abbott Park, IL, USA). Serum calcium and inorganicTwo-dimensional (2-D) guided M-mode echocardio-
phosphate were measured by automated enzymaticgrams were obtained for measurements including inter-
methods with a Hitachi auto-analyzer 7600 (Hitachi Ltd,ventricular septum thickness (IVS), posterior wall thick-
Tokyo, Japan) and Boerhringer Mannheim Diagnosticsness (PWT), and LV internal dimensions in the diastole
reagents (Mannheim, Germany). Plasma intact parathy-and systole [23]. LVM was calculated from both the
roid hormone levels were determined using the IRMA2-D echocardiographic measurements according to the
assay (DiaSorin Inc. Stillwater, MN, USA).truncated ellipsoidal formula [24] and the M-mode mea-
surements [25]. The two independent calculations were
Statistical analysis
significantly correlated in the following regression equa-
Data were expressed as mean  SD for continuoustion: LVM (M-mode)  1.18  LVM (2-D)  30 (r 
variables and as proportions for categorical variables.0.81, P 0.001). Since some cardiac indexes were derived
Between-group comparisons were performed by one-from the same M-mode measurements and this might cause
way analysis of variance (ANOVA) with Duncan post-inherent interdependency between the M-mode derived
hoc test for continuous variables and by the Chi-squareLVM and other cardiac indices, we used only the 2-D
test for categorical variables. Pearson’s correlation coef-derived LVM for all correlation and regression analyses.
ficients between LVM and other parameters were calcu-LV EF was calculated from the M-mode measurements
lated. Only parameters with significant correlation withaccording to Teichholz et al’s formula [26].
LVM were included in the subsequent multiple regres-Stroke volume (SV) was derived from the aortic annu-
sion models. Multiple linear regression analysis was per-lar cross-sectional area multiplied by the velocity integral
formed to identify the independent determinants ofof LV outflow, and CO from the SV multiplied by heart
LVM in each category, namely, the blood pressure andrate. Cardiac index was calculated as CO/BSA. LV end-
heart rate, antropometrics, volume status, cardiac struc-diastolic volume (LVEDV) and end-systolic volume
ture, cardiac function, arterial structure, arterial functionwere directly measured from a frozen 2-D image of the
and others, respectively. The independent determinantsapical four-chamber view according to the single plane
of LVM in each category (except for the parameters ofarea-length method [24]. Therefore, LVM, LVEDV, LV
the cardiac structure) were subjected to further forwardend-systolic volume and EF were all independent mea-
stepwise multiple regression analysis. By calculating thesurements or calculation. End systolic meridional stress
ratios of individual partial r 2 to the full model r 2, theto volume ratio (ESSV), an index of LV contractility
relative importance of each independent variable in[27], was calculated as:
the full model was determined. All statistical tests were
two-tailed with a P value 0.05 to indicate statisticalEnd-systolic pressure  LV end-systolic dimension
LV wall thickness  LV end-systolic volume significance.
(Eq. 1)
RESULTSInferior vena cava diameter (IVCD) at the level just
Clinical and cardiovascular parameters in hemodialysisbelow the diaphragm in the hepatic segment was mea-
patients and normal controlssured by 2-D guided M-mode echocardiography when
patients were in a supine position. With simultaneous The characteristics of the study groups are shown in
electrocardiographic recording, IVCD was measured be- Table 1. The three groups were comparable in age, gen-
fore the P wave of ECG during expiration and was ex- der and anthropometric indices. As compared with the
pressed as index to BSA in mm/m2 [28]. NTNR and NTHD groups, the HTHD group had obvi-
ous pressure and volume overload along with greater
Uremia related modulators and laboratory evaluation LV wall thickness, chamber size and mass. The HTHD
The interdialytic weight gain (IWG) was the average group had significantly higher brachial and carotid blood
of the 25 consecutive differences of the patient’s body pressure, greater LVEDV, IVS, PWT, LVM, SV, CO,
weight at the beginning of HD minus the weight after cardiac index and lower ESSV than the NTNR group.
the previous HD session prior to the comprehensive The HTHD group also had greater aortic diameter, ca-
hemodynamic examination, and was expressed both as rotid diameter, carotid IMT, carotid elastic modulus,
absolute value and percentage of the dry body weight. AGI and PWV than the NTNR subjects.
The averages of the SBP (SBPavg) and DBP (DBPavg) In contrast, the NTHD group had similar brachial
at the beginning of HD from the 25 consecutive HD and carotid blood pressure, large artery function, LV
sessions also were calculated. The adequacy of hemodial- chamber size and SV as the NTNR group. However, the
ysis dosage was calculated with the formula Kt/V [29]. NTHD subjects still had greater wall thickness and LVM,
along with greater CO, lower TPR, lower ESSV andHemoglobin and hematocrit measurements were per-
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Table 1. Characteristics of normal controls and hemodialysis (HD) subjects
NTNR NTHD HTHD
N  46 N  40 N  41
Age years 53.715.3 53.714.4 54.613.1
Sex M/F 18/28 18/22 25/16
HD duration days 16591432 12491525
Blood pressure and heart rate
SBP mm Hg 11514 10919b 14623c
SBPc mm Hg 10714 10016b 13422c
DBP mm Hg 7010 6512b 8113c
MBP mm Hg 8511 8013b 10314c
PP mm Hg 458 4411b 6519c
PPc mm Hg 348 348b 5217c
SBPavg mm Hg 122.313.9b 150.38.4
DBPavg mm Hg 73.56.3b 85.04.6
Heart rate bpm 618 7112a 7111c
Anthropometrics
Height cm 1608 1587 1619
Weight kg 62.713.2 58.89.0 59.111.0
Body surface area m2 1.650.19 1.590.14 1.620.18
Body mass index kg/m2 24.34.2 23.63.0 22.63.2
Waist-to-hip ratio 0.840.08 0.870.07 0.850.06
Volume status
Fat free mass kg 38.89.6 33.57.7 35.711.9
Extracellular fluid L 13.32.6 12.02.4 12.52.6
Intracellular fluid L 16.05.0 13.33.6 14.66.9
IVCD mm/m2 8.92.1 6.92.2a 8.02.8
Cardiac structure
LVM (by 2-D) g 11124 13435a,b 17341c
LVM (by M-mode) g 15244 18847a,b 24355c
IVS cm 0.970.22 1.110.15a 1.190.17c
PWT cm 0.890.12 1.020.12a,b 1.120.14c
LVEDV mL 889 9311b 10613c
Cardiac function
Stroke volume mL 6612 6617b 7713c
Cardiac output L/min 3.90.7 4.61.1a,b 5.41.1c
Cardiac index L/min/m2 2.40.4 2.90.8a,b 3.30.7c
Ejection fraction % 747 756b 718
ESSV mm Hg/mL 13.14.2 9.23.0a 9.54.0c
Arterial structure
Aortic diameter cm 2.90.3 3.10.3b 3.30.4c
Carotid diameter cm 0.560.07 0.610.09a,b 0.670.08c
Carotid IMT cm 0.0780.012 0.0880.022a 0.0890.016c
Arterial function
Elastic modulus KPa · 103 0.260.09 0.280.15b 0.470.43c
Augmentation index % 2211 1720b 3117c
Pulse wave velocity cm/s 824208 909240b 1156414c
AC mL/mm Hg 1.180.39 1.320.63 1.250.49
TPR mm Hg/L 225 184a 205
Others
Hematocrit % 40.33.0 30.83.6a 30.03.4c
Hemoglobin g/dL 13.40.9 10.31.3a 10.01.2c
Kt/V 1.520.25 1.480.28
Interdialytic weight gain kg 3.263.26 2.840.95
Interdialytic weight gain % 5.64.7 4.91.5
Calcium mg/dL 9.30.9 9.30.7
Phosphate mg/dL 5.11.1 5.21.2
Intact-parathyroid hormone pg/dL 265388 145146
Abbreviations are: NTNR, normotensive normal renal function; NTHD, normotensive hemodialysis; HTHD, hypertensive hemodialysis; AC, total arterial compli-
ance; DBP, diastolic blood pressure; DBPavg, pre-dialysis DBP from 25 consecutive dialysis sessions; ESSV, end-systolic meridional stress to volume ratio; HD,
hemodialysis; IMT, intima-media thickness; IVCD, inferior vena cava diameter; IVS, interventricular septum thickness; LVEDV, left ventricular end-diastolic volume;
LVM, left ventricular mass; MBP, mean blood pressure; PP, pulse pressure; PPc, carotid pulse pressure; PWT, posterior wall thickness; SBP, systolic blood pressure;
SBPavg, pre-dialysis systolic blood pressure averaged from 25 consecutive hemodialysis sessions; SBPc, carotid systolic blood pressure; TPR, total peripheral resistance.
a NTNR vs. NTHD, P  0.05
b NTHD vs. HTHD, P  0.05
c NTNR vs. HTHD, P  0.05
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Table 2. Univariate relations of LVM with anthropometrical, cardiac and vascular indices in the normal controls and HD subjects
NTNR NTHD HTHD
N  46 N  40 N  41
Age years 0.19 (0.200) 0.17 (0.290) 0.17 (0.295)
Blood pressure and heart rate
SBP mm Hg 0.39 (0.008)a 0.33 (0.038)a 0.25 (0.117)
SBPc mm Hg 0.23 (0.136) 0.36 (0.021)a 0.24 (0.137)
DBP mm Hg 0.45 (0.002)a 0.32 (0.043)a 0.02 (0.921)
MBP mm Hg 0.45 (0.002)a 0.34 (0.031)a 0.13 (0.435)
PP mm Hg 0.10 (0.527) 0.20 (0.216) 0.31 (0.049)a
PPc mm Hg 0.06 (0.677) 0.25 (0.118) 0.32 (0.039)a
SBPavg mm Hg 0.39 (0.014)a 0.18 (0.267)
DBPavg mm Hg 0.36 (0.025)a 0.02 (0.905)
Heart rate bpm 0.20 (0.183) 0.18 (0.264) 0.08 (0.632)
Anthropometrics
Height cm 0.52 (0.001)a 0.36 (0.024)a 0.16 (0.322)
Weight kg 0.68 (0.001)a 0.37 (0.018)a 0.15 (0.335)
Body surface area m2 0.69 (0.001)a 0.41 (0.009)a 0.17 (0.300)
Body mass index kg/m2 0.55 (0.001)a 0.18 (0.269) 0.11 (0.509)
Waist-to-hip ratio 0.64 (0.001)a 0.28 (0.081) 0.36 (0.020)a
Volume status
Fat free mass kg 0.63 (0.001)a 0.19 (0.239) 0.12 (0.446)
Extracellular fluid L 0.77 (0.001)a 0.36 (0.025)a 0.35 (0.026)a
Intracellular fluid L 0.52 (0.001)a 0.10 (0.556) 0.03 (0.840)
IVCD mm/m2 0.31 (0.039)a 0.14 (0.405) 0.003 (0.986)
Cardiac structure
IVS cm 0.71 (0.001)a 0.44 (0.005)a 0.53 (0.001)a
PWT cm 0.79 (0.001)a 0.59 (0.001)a 0.48 (0.002)a
LVEDV mL 0.68 (0.001)a 0.54 (0.001)a 0.45 (0.003)a
Cardiac function
Stroke volume mL 0.54 (0.001)a 0.33 (0.036)a 0.49 (0.001)a
Cardiac output L/min 0.43 (0.003)a 0.26 (0.107) 0.46 (0.002)a
Cardiac index L/min/m2 0.01 (0.971) 0.10 (0.553) 0.39 (0.011)a
Ejection fraction % 0.26 (0.080) 0.33 (0.037)a 0.44 (0.004)a
ESSV mm Hg/mL 0.69 (0.001)a 0.47 (0.002)a 0.37 (0.018)a
Arterial structure
Aortic diameter cm 0.47 (0.001)a 0.29 (0.061) 0.18 (0.258)
Carotid diameter cm 0.36 (0.014)a 0.29 (0.067) 0.49 (0.001)a
Carotid IMT cm 0.50 (0.001)a 0.52 (0.001)a 0.11 (0.515)
Arterial function
Elastic modulus KPa · 103 0.15 (0.330) 0.10 (0.539) 0.41 (0.009)a
Augmentation index % 0.19 (0.212) 0.12 (0.452) 0.01 (0.943)
Pulse wave velocity cm/s 0.35 (0.021)a 0.41 (0.008)a 0.34 (0.031)a
AC mL/mm Hg 0.56 (0.001)a 0.09 (0.618) 0.01 (0.941)
TPR mm Hg/L 0.11 (0.453) 0.03 (0.847) 0.37 (0.017)a
Others
Hematocrit % 0.34 (0.046)a 0.08 (0.636) 0.23 (0.147)
Hemoglobin g/dL 0.38 (0.024)a 0.11 (0.493) 0.27 (0.092)
Kt/V 0.37 (0.017)a 0.29 (0.066)
Interdialytic weight gain kg 0.07 (0.676) 0.25 (0.110)
Interdialytic weight gain % 0.04 (0.793) 0.21 (0.188)
Calcium mg/dL 0.09 (0.578) 0.23 (0.146)
Phosphate mg/dL 0.08 (0.623) 0.07 (0.646)
Intact parathyroid hormone pg/dL 0.04 (0.819) 0.01 (0.971)
Numbers are correlation coefficients, and numbers in parentheses are P values. Abbreviations are: NTNR, normotensive normal renal function; NTHD, normotensive
hemodialysis; HTHD, hypertensive hemodialysis; AC, total arterial compliance; DBP, diastolic blood pressure; DBPavg, pre-dialysis DBP from 25 consecutive dialysis
sessions; ESSV, end-systolic meridional stress to volume ratio; HD, hemodialysis; IMT, intima-media thickness; IVCD, inferior vena cava diameter; IVS, interventricular
septum thickness; LVEDV, left ventricular end-diastolic volume; LVM, left ventricular mass; MBP, mean blood pressure; PP, pulse pressure; PPc, carotid pulse
pressure; PWT, posterior wall thickness; SBP, systolic blood pressure; SBPavg, pre-dialysis systolic blood pressure averaged from 25 consecutive hemodialysis sessions;
SBPc, carotid systolic blood pressure; TPR, total peripheral resistance.
a Statistically significant
smaller IVCD than the NTNR group. On the other hand, bin, serum calcium, phosphate and intact-parathyroid
hormone values.the NTHD subjects had comparable aortic diameter,
carotid elastic modulus, AGI and PWV, but greater ca-
Determinants of LVMrotid diameter and carotid IMT as compared with the
NTNR group. Blood pressure and heart rate. Left ventricular mass
was significantly related to SBP, DBP and MBP (Ta-In terms of HD parameters, the NTHD and HTHD
patients had similar Kt/V, IWG, hematocrit, hemoglo- ble 2), and DBP was the significantly independent deter-
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Table 3. Multiple regression models of LVM in each category of variables
NTNR NTHD HTHD
N  46 N  40 N  41
Blood pressure Model r 2  0.202 Model r 2  0.149 Model r 2  0.105
DBP mm Hg 0.450 (0.002)
PPc mm Hg 0.324 (0.039)
Averaged SBP mm Hg 0.386 (0.014)
Anthropometrics Model r 2  0.553 Model r 2  0.166 Model r 2  0.130
Body surface area m2 0.475 (0.001) 0.408 (0.009)
Waist-to-hip ratio 0.349 (0.010) 0.361 (0.020)
Volume status Model r 2  0.590 Model r 2  0.126 Model r 2  0.121
Extracellular fluid L 0.768 (0.001) 0.355 (0.025) 0.348 (0.026)
Cardiac structure Model r 2  0.808 Model r 2  0.575 Model r 2  0.467
IVS cm 0.310 (0.001) 0.512 (0.001)
PWT cm 0.408 (0.001) 0.537 (0.001)
LVEDV mL 0.395 (0.001) 0.484 (0.001) 0.429 (0.001)
Cardiac function Model r 2  0.576 Model r 2  0.303 Model r 2  0.513
Stroke volume mL 0.290 (0.043) 0.453 (0.001)
Ejection fraction % 0.440 (0.001)
ESSV mm Hg/mL 0.636 (0.001) 0.440 (0.003) 0.271 (0.026)
Cardiac output L/min 0.313 (0.003)
Arterial structure Model r 2  0.250 Model r 2  0.271 Model r 2  0.245
Carotid diameter cm 0.495 (0.001)
Carotid IMT cm 0.500 (0.001) 0.521 (0.001)
Arterial function Model r 2  0.517 Model r 2  0.171 Model r 2  0.290
Elastic modulus KPa · 103 0.392 (0.007)
Pulse wave velocity cm/s 0.453 (0.001) 0.413 (0.008)
AC mL/mm Hg 0.636 (0.001)
TPR mm Hg/L 0.355 (0.013)
Others Model r 2  0.146 Model r 2  0.140
Hemoglobin g/dL 0.382 (0.024)
Kt/V 0.374 (0.017)
Numbers are standardized regression coefficients, and numbers in parentheses are P values, Abbreviations are: NTNR, normotensive normal renal function;
NTHD, normotensive hemodialysis; HTHD, hypertensive hemodialysis; AC, total arterial compliance; DBP, diastolic blood pressure; ESSV, end-systolic meridional
stress to volume ratio; IMT, intima-media thickness; IVS, interventricular septal thickness; LVEDV, left ventricular end-diastolic volume; PPc, carotid pulse pressure;
PWT, posterior wall thickness; PWV, pulse wave velocity; TPR, total peripheral resistance.
minant of LVM in this category in the NTNR subjects status parameters (Table 2) in both NTHD (r 2  0.126)
and HTHD groups (r 2  0.121; Table 3).(r 2  0.202; Table 3). In the NTHD subjects, LVM was
significantly related to SBP, SBPc, DBP, MBP, SBPavg Cardiac structure. Left ventricular mass was signifi-
cantly related to IVS, PWT and LVEDV in the NTNR,and DBPavg (Table 2), and SBPavg was the significantly
independent determinant (r 2  0.149; Table 3). In con- NTHD and HTHD groups (Table 2). In the NTNR sub-
jects, all three parameters were significantly independenttrast, LVM was significantly related PP and PPc (Ta-
ble 2), and PPc was the significantly independent deter- determinants of LVM (r 2 0.808; Table 3). In the NTHD
group, PWT and LVEDV were significantly independentminant in the HTHD patients (r 2  0.105; Table 3).
Anthropometrics. Left ventricular mass was signifi- determinants (r 2  0.575; Table 3), while in the HTHD
group, IVS and LVEDV were significantly independentcantly related to height, weight, BSA, BMI, and WHR
(Table 2), and BSA and WHR were significantly inde- determinants (r 2  0.467; Table 3).
Cardiac function. In the NTNR group, LVM was sig-pendent determinants of LVM in this category in the
NTNR subjects (r 2  0.553; Table 3). LVM was signifi- nificantly positively related to SV and CO, and was sig-
nificantly negatively related to ESSV (Table 2); ESSVcantly related to height, weight and BSA (Table 2), and
BSA was the significantly independent determinant in and CO were the significantly independent determinants
(r 2  0.576; Table 3). In the NTHD group, LVM wasthe NTHD group (r 2 0.166; Table 3). In contrast, WHR
was the only anthropometric parameter (Table 2) that significantly positively related to SV, and was signifi-
cantly negatively related to EF and ESSV (Table 2),was significantly related to LVM in the HTHD group
(r 2  0.130; Table 3). and ESSV and SV were the significantly independent
determinants (r 2  0.303; Table 3). In the HTHD group,Volume status. The LVM was significantly positively
related to FFM, ECF and ICF, and was significantly LVM was significantly positively related to SV, CO and
cardiac index, and was significantly negatively related tonegatively related to IVCD (Table 2), and ECF was the
only significantly independent determinant in the NTNR EF and ESSV (Table 2), and SV, EF and ESSV were
the significantly independent determinants (r 2  0.513;group (r 2  0.590; Table 3). On the other hand, LVM
was only significantly related to ECF among the volume Table 3).
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Arterial structure. Left ventricular mass was signifi- four parameters explained 61.7% of the total variance
of LVM (P  0.001). In the HTHD patients, the signifi-cantly related to aortic diameter, carotid diameter and
carotid IMT (Table 2), and IMT was the only significantly cantly independent determinants of LVM in the full
model were carotid diameter (  0.404, P 0.001), SVindependent determinant in the NTNR group (r 2 
0.250; Table 3). On the other hand, IMT and carotid (  0.404, P  0.001), EF (  0.391, P  0.001) and
ESSV (  0.282, P  0.006). These four parametersdiameter were the only significant determinant of LVM
among arterial structure parameters (Table 2) in the explained 67.2% of the total variance of LVM (P 
0.001). The relative contribution of each of the determi-NTHD (r 2  0.271) and HTHD (r 2  0.245) groups
(Table 3), respectively. nants to the variance of LVM in each group is shown in
Figure 1.Arterial function. Left ventricular mass was signifi-
cantly related to PWV and AC (Table 2), and both were
significantly independent determinants in the NTNR
DISCUSSION
group (r 2  0.517; Table 3). On the other hand, PWV
Previous studies of the determinants of LVM in uremicwas the only significant determinant of LVM among
or non-uremic subjects were universally based on LVMthe arterial function parameters (Table 2) in the NTHD
calculated from M-mode echocardiographic measure-group (r 2  0.171; Table 3). LVM was significantly re-
ments. When some independent variables, such as EF,lated to carotid incremental elastic modulus, PWV and
LVEDV and ESSV, also were calculated from the sameTPR (Table 2), and incremental elastic modulus and
M-mode measurements, the interdependency betweenTPR were significantly independent determinants in the
the dependent variable and the independent variablesHTHD patients (r 2  0.290; Table 3).
may raise serious concern. The present study used theOthers. Left ventricular mass was significantly related
independently measured 2-D–derived LVM for analysisto hematocrit and hemoglobin levels (Table 2), and he-
that should substantially reduce such interdependency.moglobin was the significantly independent determinant
The major findings in this study are (1) optimal HDamong the two in the NTNR group (r 2 0.146; Table 3).
alone can normalize arterial blood pressure and largeOn the other hand, LVM was not related to IWG, hema-
artery function to levels equivalent to the non-uremictocrit, hemoglobin, or serum levels of calcium, phosphate
normotensive controls, indicating the effective reductionor intact parathyroid hormone in both the NTHD and
of pressure overload; (2) optimal HD also can effectivelyHTHD subjects. However, LVM was significantly nega-
reduce volume overload as reflected in the measure-tively related to Kt/V in the NTHD group (r 2  0.140;
ments of ECF, LVEDV, SV, and IVCD in the NTHDTable 3) but not in the HTHD group. The relationship
group; (3) persistent flow overload and subclinical LVbetween Kt/V and LVM was partly related to the gender
dysfunction were noted in the NTHD subjects; (4) effec-effect (Kt/V for NTHD men and women: 1.40  0.22
tive reduction of pressure and volume overload by opti-vs. 1.61  0.23, P  0.007). However, Kt/V remained
mal HD alone may partially improve the changes of thesignificantly related to LVM when sex was accounted
cardiac and vascular structure secondary to hemody-for (data not shown).
namic overload; (5) while the LVM in the NTNR group
Full models is mainly determined by volume status, body size, blood
pressure, and the structural and functional coupling be-The significant independent determinants of LVM in
tween heart and large arteries (77.2% of the total vari-the categories of blood pressure, anthropometrics, vol-
ance of LVM), the LVM in the NTHD subjects is onlyume status, cardiac function, arterial structure, arterial
partially determined by the hemodynamic factors (61.7%function, and others were selected for generation of full
of the total variance of LVM), implying the significancemodels of regression analysis. The parameters in the cate-
of non-hemodynamic factors (neurohumoral) in the de-gory of cardiac structure were not included because of
velopment of LVH in these patients.the strong inherent relationship with LVM, even though
all were independent measurements. In the NTNR sub-
Determinants of LVM in the normal renaljects, the significantly independent determinants of LVM
function populationin the full model were ECF (standardized regression
In the NTNR subjects, LVM is largely determined bycoefficient   0.319, P  0.014), WHR (  0.242, P 
body size and stroke work, which is a simple summary0.031), DBP (  0.304, P  0.002) and ESSV ( 
of LV workload and represents an approximate measure0.334, P  0.005). These four parameters explained
of the interaction between the two hemodynamic compo-77.2% of the total variance of LVM (P  0.001). In the
nents (pressure and volume) [30]. Appropriateness ofNTHD group, the significantly independent determi-
LVM to loading condition and body size can be assessednants of LVM in the full model were ESSV ( 0.530,
by relating observed LVM to levels predicted by an equa-P  0.001), SBPavg (  0.373, P  0.002), PWV ( 
0.314, P  0.008) and SV (  0.285, P  0.010). These tion including sex, body height, SBP, and SV [30]. In the
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Fig. 1. Relative importance of each independent noncardiac structural variable in the final main effects multiple regression model is shown for
the NTNR subjects (A), NTHD patients (B) and HTHD patients (C ). Model r 2 is the proportion of variance of LVM that can be explained by
the full model. Partial r 2 of each individual variable was calculated from the stepwise multiple regression approach. Ratio of partial r 2 to model
r 2 is the proportion of the model variance that can be explained by the independent variable. Abbreviations are: NTNR, normotensive normal
renal function; NTHD, normotensive hemodialysis; HTHD, hypertensive hemodialysis; Carotid, carotid diameter; DBP, diastolic blood pressure;
ECF, extracellular fluid; EF, ejection fraction; ESSV, end-systolic meridional stress-to-volume ratio; SBPavg, averaged systolic blood pressure
from 25 consecutive sessions; SV, stroke volume; WHR, waist-to-hip ratio.
Framingham study of 2226 men and 2746 women, age, tients [16]. Conditions such as anemia [32], arteriovenous
shunts, interdialytic weight change and overhydrationheight, SBP and BMI were statistically significant and
independent correlates of LVM in both sexes [31]. In a induce a state of chronic flow overload. Hypertension,
stiffening of the aorta and major arteries, and increasedpopulation of 1315 Chinese subjects, the optimum multi-
variate linear regression main effects model for LVM arterial wave reflection are the documented causes for
the chronic pressure overload [33]. On the other hand,had an adjusted model r2 of 0.740, with 98% of the model
variance accounted for by the five independent determi- various non-hemodynamic factors responsible for LVH
in the ESRD patients are recognized also, including hy-nants: SV (49.6%), SBP (30.7%), ESSV (14.7%), BMI
(1.8%) and aortic root diameter (1.6%) [13]. perparathyroidism [34], increased plasma endothelin
[35], renin-angiotensin system [9], hypoalbuminemiaIn the present study of 46 NTNR subjects, ECF, WHR,
DBP and ESSV were identified as independent determi- [36], and the uremic internal milieu [37]. In the present
study, serum calcium, inorganic phosphate, and intact-nants of LVM, when the parameters of cardiac structure
were not included. ECF is mainly determined by volume parathyroid hormone were not significantly related to
LVM, implying a minor role of hyperparathyroidism instatus and body size (correlation coefficient between
ECF and BSA  0.89, P  0.001). Blood pressure is a the development of LVH in HTHD patients.
The 41 HTHD patients in our study were character-parameter of cardiac and vascular function [13]. The
importance of ESSV in determining LVM confirms pre- ized by significantly higher central and peripheral SBP
and PP, stiffer carotid artery and aorta, and strongervious findings [27]. Our results are compatible with the
notion that body size, and the structural and functional arterial wave reflection than either the NTNR or the
NTHD subjects, implying the presence of obvious pres-coupling between heart and arteries are the principal
determinants of LVM in the normal population. sure overload. In addition, the greater LVEDV, SV, CO
and CI in the HTHD patients indicated the presence
Determinants of LVM in the hypertensive significant volume/flow overload.
uremic patients Since the HTHD patients were asymptomatic and
without a previous history of heart disease, the lowerBoth pressure and volume components of the hemody-
namic load are evident in the hypertensive ESRD pa- ESSV in the presence of normal EF and LV dilation as
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compared to the NTNR subjects indicates the presence Therefore, we cannot rule out the possibility that the
of subclinical LV dysfunction. In the full model, carotid NTHD patients were slightly dehydrated, nor were we
artery diameter, SV, EF and ESSV were identified as certain whether the equilibration of intra- and extravas-
independent determinants of LVM. Since arterial struc- cular volume status had been reached on the non-dialysis
ture is significantly correlated with arterial function (be- day. In any case, the normal LVEDV and SV along
tween carotid diameter and elastic modulus, r  0.32, with small IVCD argues against the presence of volume
P 0.043; between carotid diameter and PWV, r 0.51, overload in NTHD patients. On the other hand, the
P  0.001), the full model might further emphasize the NTHD group still had greater CO and CI than the NTNR
importance of pressure overload (carotid diameter), vol- subjects, implying the presence of flow overload. The
ume/flow (SV) overload and subclinical LV dysfunction increased CO and CI in the NTHD group were responsi-
(EF and ESSV) in the development of LVH in HTHD ble for the decreased TPR and were directly related to
patients [11]. the faster heart rate as compared to the NTNR subjects.
It has been demonstrated that the calculated LVMI by The flow overload in the absence of volume overload in
echocardiography increases with ECF volume expansion the NTHD group was likely due to the inherent arterio-
and the calculated LVMI could decrease by approxi- venous fistulae and anemia that may not be subject to
mately 26 g/m2 during a dialysis session, as a result of aggressive fluid removal [5].
fluid removal [38]. As shown in Tables 2 and 3, ECF The NTHD patients had similar blood pressure and
was highly related to LVM (r  0.77) and accounted for large artery function as the NTNR subjects, indicating
55.5% of the total variance of LVM in the NTNR sub- the substantial reduction of pressure overload with opti-
jects. In contrast, ECF was only weakly related to LVM mal HD alone. However, the NTHD patients still had
in both NTHD and HTHD patients. The results partly greater wall thickness and LVM, and lower ESSV than
may be due to problems with the bioimpedance measure- the NTNR subjects. The residual or persistent cardiovas-
ments [39], or may suggest that the role of salt and water cular structural abnormalities in the NTHD group sug-
overload in the pathogenesis of LVH in both NTHD and gest a limitation of adequate HD in the reversal of abnor-
HTHD patients may not be as important as previously mal cardiovascular adaptation. In the full model, ESSV,
thought. SBPavg, PWV and SV were identified as independent de-
terminants of LVM in the NTHD group and ESSV con-Determinants of LVM in the normotensive
tributed 35.5% of the variance explained by the modeluremic patients
(Fig. 1B), implying the importance of subclinical LV
Although the hemodynamic overload is responsible dysfunction in the development of LVH similar to that
for the development of LVH in most ESRD patients, it
in the HTHD group. The persistent subclinical LV dys-
remains to be determined whether substantial hemody-
function might be due to the persistent flow overloadnamic overload is present in the ESRD patients with
and/or the intrinsic uremic factor responsible for the LVblood pressure normalized to the optimal levels.
dysfunction in the ESRD patients [40].London et al found an enlargement of the LV end-
diastolic diameter in 57 normotensive HD patients (aver- Limitations of the study
aged SBP 137 mm Hg) in comparison to 40 healthy
The present study was not an interventional studycontrols matched for sex, age and blood pressure [40].
evaluating the effect of optimal HD on the hemodynamicEnlargement of the ventricle was related to anemia, the
overload and the changes of cardiovascular structurehemodynamic effect of arteriovenous fistula and second-
and function. Instead, this was a prospectively conductedary hyperparathyroidism [40].
case-control study with its inherent limitations in theIn the present study, serum calcium, inorganic phos-
interpretation of results. Although the levels of bloodphate and intact-parathyroid hormone were not signifi-
pressure in the NTHD group before the blood pressurecantly related to LVM in the NTHD. Furthermore, the
was controlled were not available, the inclusion of twoNTHD subjects (averaged SBP 109 mm Hg) had compa-
control groups, namely, the NTNR and HTHD groups,rable LVEDV and SV but greater LVM in comparison
enabled us to speculate reasonably on the potential limi-with the NTNR subjects. IVCD has been shown in previ-
tations of the optimal HD by aggressive fluid removalous studies to be a simple and reliable tool to estimate
alone on the reverse remodeling of cardiovascular struc-‘dry weight’ in chronic hemodialysis patients [28]. An
ture and function. All HD patients in this study wereIVCD of less than 8 mm/m2 indicates under-hydration
maintained a hemoglobin level of around 10 g/dL as[28, 41], but significant bioelectrical impedance analysis
recommended by our National Health Insurance System,changes only appear in major under-hydration (IVCD
which is lower than 11 to 12 g/dL, a range considered6.5 mm/m2) [42]. While the NTHD patients had smaller
currently to be the lower limit of adequacy in terms ofIVCD (6.9 mm/m2) than the NTNR subjects (8.9 mm/m2),
their ICF and ECF values were not significantly different. LV damage. This less than ideal level of hemoglobin
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motensive hemodialysis group; NTNR, normotensive normal renalmight partially be responsible for the flow overload ob-
function group; MBP, mean blood pressure; PP, pulse pressure; PPc,
served in both the NTHD and HTHD patients. pulse pressure in the common carotid artery; PWT, posterior wall
thickness; PWV, pulse wave velocity; SBP, systolic blood pressure;The HTHD patients received regular antihypertensive
SBPavg, averaged systolic blood pressure from 25 consecutive dialysismedication that might have had favorable effects on the
sessions; SBPc, systolic blood pressure in the common carotid artery;
cardiovascular function and structural remodeling [43], SV, stroke volume; TPR, total peripheral vascular resistance; WHR,
waist-to-hip ratio.and this might explain the failure of arterial wave reflec-
tion (as indexed by AGI) as an important determinant
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